Page 402 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 402
Steinhäuser Verlag 410 E
SuperSonic Imagine 320 E
510, rue René Descartes, Le Jardins de la Duranne Bat F
Aix en Provence, 13857
France
www.supersonicimagine.com
SuperSonic Imagine designs, develops and markets a revolutionary ultrasound system,
Aixplorer®, which can acquire images 200 times faster than conventional systems.
ShearWave™ Elastography, enabled by the Aixplorer UltraFast platform, is the only
technology that provides robust liver stiffness measurements with real-time image guidance.
Clinical studies have demonstrated that SuperSonic Imagine’s ShearWave Elastography is
reliable and easy to use. It provides maps and measurements of liver stiffness that help
in assessing the stage of liver fibrosis and in monitoring disease progression in a single
acquisition. This non-invasive technology has the potential to reduce the number of liver
biopsies.
Synageva BioPharma Corp. 240 A
33 Hayden Ave
Lexington, 02446
The United States
www.synageva.com
Synageva is a biopharmaceutical company focused on the discovery, development, and
commercialization of therapeutic products for patients with rare diseases. The company’s
pipeline programs consist of protein therapeutics for rare diseases with unmet medical need
at various stages of development including the lead program, Kanuma™ (sebelipase alfa)
for lysosomal acid lipase deficiency (LAL D), SBC-103 for mucopolysaccharidosis IIIB
(MPS IIIB, also known as Sanfilippo B syndrome), and SBC-105 for generalized arterial
calcification of infancy (GACI) and other rare calcification diseases.
INDUSTRY INFORMATION Virology Education 340 M
Bitstraat 106
Utrecht, 3572 BJ
The Netherlands
www.virology-education.com
The standards of care in treatment of viral diseases are in continuous development. Experts
are incessantly searching for better ways to treat infected patients and solve the problems
they entail. Many new diagnostic technologies are being developed and an abundance of
information and knowledge is being gathered.
Virology Education feels that there is a need for educational programs dealing with this
rapidly changing and expanding scientific and medical knowledge. New ideas and practices
are evolving through the active interactions between the practicing clinicians, laboratory
scientists and the leading experts. This interaction is the basis of Virology Education’s
workshops and educational programmes.
402 The International Liver Congress™ 2015 • ILC Programme
SuperSonic Imagine 320 E
510, rue René Descartes, Le Jardins de la Duranne Bat F
Aix en Provence, 13857
France
www.supersonicimagine.com
SuperSonic Imagine designs, develops and markets a revolutionary ultrasound system,
Aixplorer®, which can acquire images 200 times faster than conventional systems.
ShearWave™ Elastography, enabled by the Aixplorer UltraFast platform, is the only
technology that provides robust liver stiffness measurements with real-time image guidance.
Clinical studies have demonstrated that SuperSonic Imagine’s ShearWave Elastography is
reliable and easy to use. It provides maps and measurements of liver stiffness that help
in assessing the stage of liver fibrosis and in monitoring disease progression in a single
acquisition. This non-invasive technology has the potential to reduce the number of liver
biopsies.
Synageva BioPharma Corp. 240 A
33 Hayden Ave
Lexington, 02446
The United States
www.synageva.com
Synageva is a biopharmaceutical company focused on the discovery, development, and
commercialization of therapeutic products for patients with rare diseases. The company’s
pipeline programs consist of protein therapeutics for rare diseases with unmet medical need
at various stages of development including the lead program, Kanuma™ (sebelipase alfa)
for lysosomal acid lipase deficiency (LAL D), SBC-103 for mucopolysaccharidosis IIIB
(MPS IIIB, also known as Sanfilippo B syndrome), and SBC-105 for generalized arterial
calcification of infancy (GACI) and other rare calcification diseases.
INDUSTRY INFORMATION Virology Education 340 M
Bitstraat 106
Utrecht, 3572 BJ
The Netherlands
www.virology-education.com
The standards of care in treatment of viral diseases are in continuous development. Experts
are incessantly searching for better ways to treat infected patients and solve the problems
they entail. Many new diagnostic technologies are being developed and an abundance of
information and knowledge is being gathered.
Virology Education feels that there is a need for educational programs dealing with this
rapidly changing and expanding scientific and medical knowledge. New ideas and practices
are evolving through the active interactions between the practicing clinicians, laboratory
scientists and the leading experts. This interaction is the basis of Virology Education’s
workshops and educational programmes.
402 The International Liver Congress™ 2015 • ILC Programme
